Patent number: 6770627
Abstract: A compound of formula (1), wherein: R5 is hydrogen, C1-4alkyl, R6CH2— or R6C(O)—; R6 is aryl, heteroaryl, heterocyclyl, aminoC3-6alkyl, N-(C1-4alkyl)aminoC3-6alkyl, NN-(diC1-4alkyl)aminoC3-6alkyl, or R7; wherein the aryl, heteroaryl or heterocyclyl rings may be optionally substituted with up to three substituents independently selected from nitro, C1-4alkyl, C1-4alkoxy, halo, (C1-4alkyl)sulfanyl, C1-4alkoxycarbonyl, N-(C1-4alkyl)carbamoyl, NN-(diC1-4alkyl)carbamoyl, N-(C1-4alkyl)amino or NN-(diC1-4alkyl)amino; wherein R7 is either a group or formula (2) or formula (3); and wherein L1, L2, L3, L4, R1, R2, R3, R4, R8, R9, R10, R11, R12, R13, A1, n, p, q, r and s are as defined herein. The compounds of formula (1) inhibit the interactions between MDM2 and p53 and may be useful in the treatment of cancers.
Type:
Grant
Filed:
March 7, 2001
Date of Patent:
August 3, 2004
Assignee:
AstraZeneca AB
Inventors:
Richard Wa Luke, Philip J. Jewsbury, Ronald Cotton
Publication number: 20040039203
Abstract: New process for the preparation of 1,5-disubstituted-3-amino-1,2,4-triazoles of the general formula (I), wherein the meaning of R is C1-5alkyl group; C3-13cycloalkyl-C0-4alkyl group, optionally substituted by one or more C1-3alkyl group; phenyl-C0-2alkyl-, (CH2)n-morpholino-, piperidino-, pyrrolidino- or piperazino-group, optionally substituted by one or more halogen atom, C1-3alkyl group, C1-3alkoxy group, n is 1-5, R1, R2, R3, and R4 stand independently for hydrogen, halogen, C1-6alkyl group, C1-3alkoxy group or trifuluoromethyl group, with the proviso that of the substituents R1, R2, R3, and R4 at least one stands for hydrogen.
Type:
Application
Filed:
August 4, 2003
Publication date:
February 26, 2004
Inventors:
Sandor Bokotey, Eva Csikos, Csaba Gonczi, Felix Hajdu, Istvan Hermecz, Gergely Heja, Benjamin Pdanyi, Andrea Santane Csutor, Tiborne Szomor, Gyorgyne Szvoboda